Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

Occurrence and ecological determinants of the contamination of floodplain wetlands with Klebsiella pneumoniae and pathogenic or antibiotic-resistant Escherichia coli.

Henriot C, Martak D, Cuenot Q, Loup C, Masclaux H, Gillet F, Bertrand X, Hocquet D, Bornette G.

FEMS Microbiol Ecol. 2019 Jun 24. pii: fiz097. doi: 10.1093/femsec/fiz097. [Epub ahead of print]

PMID:
31234204
2.

Management of carbapenemase-producing Enterobacteriaceae in a low incidence area: A six-year experience in a university hospital.

Emery A, Jeanvoine A, Bailly P, Gbaguidi-Haore H, Hocquet D, Bertrand X.

Infect Control Hosp Epidemiol. 2019 Jun 17:1-3. doi: 10.1017/ice.2019.149. [Epub ahead of print]

PMID:
31203818
3.

Contamination of a hospital plumbing system by persister cells of a copper-tolerant high-risk clone of Pseudomonas aeruginosa.

Jeanvoine A, Meunier A, Puja H, Bertrand X, Valot B, Hocquet D.

Water Res. 2019 Jun 15;157:579-586. doi: 10.1016/j.watres.2019.04.011. Epub 2019 Apr 10.

PMID:
30999256
4.

A nonlinear time-series analysis approach to identify thresholds in associations between population antibiotic use and rates of resistance.

López-Lozano JM, Lawes T, Nebot C, Beyaert A, Bertrand X, Hocquet D, Aldeyab M, Scott M, Conlon-Bingham G, Farren D, Kardos G, Fésűs A, Rodríguez-Baño J, Retamar P, Gonzalo-Jiménez N, Gould IM; THRESHOLDS study group.

Nat Microbiol. 2019 Jul;4(7):1160-1172. doi: 10.1038/s41564-019-0410-0. Epub 2019 Apr 8.

PMID:
30962570
5.

Carbapenem-Susceptible OXA-23-Producing Proteus mirabilis in the French Community.

Potron A, Hocquet D, Triponney P, Plésiat P, Bertrand X, Valot B.

Antimicrob Agents Chemother. 2019 May 24;63(6). pii: e00191-19. doi: 10.1128/AAC.00191-19. Print 2019 Jun.

PMID:
30962345
6.

Molecular epidemiology of Pseudomonas aeruginosa isolated from infected ICU patients: a French multicenter 2012-2013 study.

Slekovec C, Robert J, van der Mee-Marquet N, Berthelot P, Rogues AM, Derouin V, Cholley P, Thouverez M, Hocquet D, Bertrand X.

Eur J Clin Microbiol Infect Dis. 2019 May;38(5):921-926. doi: 10.1007/s10096-019-03519-w. Epub 2019 Mar 2.

PMID:
30826996
7.

Enhanced emergence of antibiotic-resistant pathogenic bacteria after in vitro induction with cancer chemotherapy drugs.

Meunier A, Nerich V, Fagnoni-Legat C, Richard M, Mazel D, Adotevi O, Bertrand X, Hocquet D.

J Antimicrob Chemother. 2019 Jun 1;74(6):1572-1577. doi: 10.1093/jac/dkz070.

PMID:
30789224
8.

Rapid antibiotic susceptibility testing on blood cultures using MALDI-TOF MS.

Sauget M, Bertrand X, Hocquet D.

PLoS One. 2018 Oct 11;13(10):e0205603. doi: 10.1371/journal.pone.0205603. eCollection 2018.

9.

panISa: ab initio detection of insertion sequences in bacterial genomes from short read sequence data.

Treepong P, Guyeux C, Meunier A, Couchoud C, Hocquet D, Valot B.

Bioinformatics. 2018 Nov 15;34(22):3795-3800. doi: 10.1093/bioinformatics/bty479.

PMID:
29931098
10.

Outbreak of IMI-1 carbapenemase-producing colistin-resistant Enterobacter cloacae on the French island of Mayotte (Indian Ocean).

Miltgen G, Bonnin RA, Avril C, Benoit-Cattin T, Martak D, Leclaire A, Traversier N, Roquebert B, Jaffar-Bandjee MC, Lugagne N, Filleul L, Subiros M, de Montera AM, Cholley P, Thouverez M, Dortet L, Bertrand X, Naas T, Hocquet D, Belmonte O.

Int J Antimicrob Agents. 2018 Sep;52(3):416-420. doi: 10.1016/j.ijantimicag.2018.05.015. Epub 2018 May 26.

PMID:
29807164
11.

Which non-carbapenem antibiotics are active against extended-spectrum β-lactamase-producing Enterobacteriaceae?

Bouxom H, Fournier D, Bouiller K, Hocquet D, Bertrand X.

Int J Antimicrob Agents. 2018 Jul;52(1):100-103. doi: 10.1016/j.ijantimicag.2018.03.014. Epub 2018 Mar 23.

PMID:
29580930
12.

A Bundle of Measures to Control an Outbreak of Pseudomonas aeruginosa Associated With P-Trap Contamination.

Gbaguidi-Haore H, Varin A, Cholley P, Thouverez M, Hocquet D, Bertrand X.

Infect Control Hosp Epidemiol. 2018 Feb;39(2):164-169. doi: 10.1017/ice.2017.304.

PMID:
29417923
13.

No effect of vancomycin MIC ≥ 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia.

Bouiller K, Laborde C, Aho SL, Hocquet D, Pechinot A, Le Moing V, Bertrand X, Piroth L, Chirouze C.

Int J Antimicrob Agents. 2018 May;51(5):721-726. doi: 10.1016/j.ijantimicag.2017.12.028. Epub 2018 Jan 3.

PMID:
29305961
14.

mcr-1-like detection in commensal Escherichia coli and Salmonella spp. from food-producing animals at slaughter in Europe.

El Garch F, de Jong A, Bertrand X, Hocquet D, Sauget M.

Vet Microbiol. 2018 Jan;213:42-46. doi: 10.1016/j.vetmic.2017.11.014. Epub 2017 Nov 21.

PMID:
29292002
15.

Genomic characterization of a local epidemic Pseudomonas aeruginosa reveals specific features of the widespread clone ST395.

Petitjean M, Martak D, Silvant A, Bertrand X, Valot B, Hocquet D.

Microb Genom. 2017 Jun 8;3(10):e000129. doi: 10.1099/mgen.0.000129. eCollection 2017 Oct.

16.

Global emergence of the widespread Pseudomonas aeruginosa ST235 clone.

Treepong P, Kos VN, Guyeux C, Blanc DS, Bertrand X, Valot B, Hocquet D.

Clin Microbiol Infect. 2018 Mar;24(3):258-266. doi: 10.1016/j.cmi.2017.06.018. Epub 2017 Jun 23.

17.

High prevalence and moderate diversity of Pseudomonas aeruginosa in the U-bends of high-risk units in hospital.

Varin A, Valot B, Cholley P, Morel C, Thouverez M, Hocquet D, Bertrand X.

Int J Hyg Environ Health. 2017 Jul;220(5):880-885. doi: 10.1016/j.ijheh.2017.04.003. Epub 2017 Apr 22.

PMID:
28456381
18.

The ST131 Escherichia coli H22 subclone from human intestinal microbiota: Comparison of genomic and phenotypic traits with those of the globally successful H30 subclone.

Nicolas-Chanoine MH, Petitjean M, Mora A, Mayer N, Lavigne JP, Boulet O, Leflon-Guibout V, Blanco J, Hocquet D.

BMC Microbiol. 2017 Mar 27;17(1):71. doi: 10.1186/s12866-017-0984-8.

19.

Can MALDI-TOF Mass Spectrometry Reasonably Type Bacteria?

Sauget M, Valot B, Bertrand X, Hocquet D.

Trends Microbiol. 2017 Jun;25(6):447-455. doi: 10.1016/j.tim.2016.12.006. Epub 2017 Jan 13. Review.

PMID:
28094091
20.

Trends of extended-spectrum β-lactamase-producing Escherichia coli sequence type 131 and its H30 subclone in a French hospital over a 15-year period.

Sauget M, Cholley P, Vannier A, Thouverez M, Nicolas-Chanoine MH, Hocquet D, Bertrand X.

Int J Antimicrob Agents. 2016 Dec;48(6):744-747. doi: 10.1016/j.ijantimicag.2016.09.023. Epub 2016 Nov 4.

PMID:
27836379
21.

mcr-1 is borne by highly diverse Escherichia coli isolates since 2004 in food-producing animals in Europe.

El Garch F, Sauget M, Hocquet D, LeChaudee D, Woehrle F, Bertrand X.

Clin Microbiol Infect. 2017 Jan;23(1):51.e1-51.e4. doi: 10.1016/j.cmi.2016.08.033. Epub 2016 Sep 8.

22.

Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study.

Mariette C, Tavernier E, Hocquet D, Huynh A, Isnard F, Legrand F, Lhéritier V, Raffoux E, Dombret H, Ifrah N, Cahn JY, Thiébaut A.

Leuk Lymphoma. 2017 Mar;58(3):586-593. doi: 10.1080/10428194.2016.1204652. Epub 2016 Jul 11.

PMID:
27397551
23.

High susceptibility of MDR and XDR Gram-negative pathogens to biphenyl-diacetylene-based difluoromethyl-allo-threonyl-hydroxamate LpxC inhibitors.

Titecat M, Liang X, Lee CJ, Charlet A, Hocquet D, Lambert T, Pagès JM, Courcol R, Sebbane F, Toone EJ, Zhou P, Lemaitre N.

J Antimicrob Chemother. 2016 Oct;71(10):2874-82. doi: 10.1093/jac/dkw210. Epub 2016 Jun 20.

24.

Appropriateness of aminoglycoside prescriptions in a French university hospital.

Muller A, Leroy J, Patry I, Hénon T, Hocquet D, Chirouze C, Bertrand X.

Med Mal Infect. 2016 Sep;46(6):308-13. doi: 10.1016/j.medmal.2016.04.009. Epub 2016 May 24.

PMID:
27230821
25.

Matrix-assisted laser desorption ionization-time of flight Mass spectrometry can detect Staphylococcus aureus clonal complex 398.

Sauget M, van der Mee-Marquet N, Bertrand X, Hocquet D.

J Microbiol Methods. 2016 Aug;127:20-23. doi: 10.1016/j.mimet.2016.05.010. Epub 2016 May 15.

PMID:
27192668
26.

Pyomelanin-producing Pseudomonas aeruginosa selected during chronic infections have a large chromosomal deletion which confers resistance to pyocins.

Hocquet D, Petitjean M, Rohmer L, Valot B, Kulasekara HD, Bedel E, Bertrand X, Plésiat P, Köhler T, Pantel A, Jacobs MA, Hoffman LR, Miller SI.

Environ Microbiol. 2016 Oct;18(10):3482-3493. doi: 10.1111/1462-2920.13336. Epub 2016 Jun 2.

27.

What happens in hospitals does not stay in hospitals: antibiotic-resistant bacteria in hospital wastewater systems.

Hocquet D, Muller A, Bertrand X.

J Hosp Infect. 2016 Aug;93(4):395-402. doi: 10.1016/j.jhin.2016.01.010. Epub 2016 Feb 1. Review.

PMID:
26944903
28.

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality.

Bouiller K, Gbaguidi-Haore H, Hocquet D, Cholley P, Bertrand X, Chirouze C.

Clin Microbiol Infect. 2016 May;22(5):451-5. doi: 10.1016/j.cmi.2016.01.018. Epub 2016 Feb 3.

29.

High prevalence of international ESBL CTX-M-15-producing Enterobacter cloacae ST114 clone in animals.

Haenni M, Saras E, Ponsin C, Dahmen S, Petitjean M, Hocquet D, Madec JY.

J Antimicrob Chemother. 2016 Jun;71(6):1497-500. doi: 10.1093/jac/dkw006. Epub 2016 Feb 4.

PMID:
26850718
30.

Fluoroquinolone Resistance Mechanisms and population structure of Enterobacter cloacae non-susceptible to Ertapenem in North-Eastern France.

Guillard T, Cholley P, Limelette A, Hocquet D, Matton L, Guyeux C, Lebreil AL, Bajolet O, Brasme L, Madoux J, Vernet-Garnier V, Barbe C, Bertrand X, de Champs On Behalf Of CarbaFrEst Group C.

Front Microbiol. 2015 Oct 23;6:1186. doi: 10.3389/fmicb.2015.01186. eCollection 2015.

31.

What It Takes to Be a Pseudomonas aeruginosa? The Core Genome of the Opportunistic Pathogen Updated.

Valot B, Guyeux C, Rolland JY, Mazouzi K, Bertrand X, Hocquet D.

PLoS One. 2015 May 11;10(5):e0126468. doi: 10.1371/journal.pone.0126468. eCollection 2015.

32.

Comparison of double-locus sequence typing (DLST) and multilocus sequence typing (MLST) for the investigation of Pseudomonas aeruginosa populations.

Cholley P, Stojanov M, Hocquet D, Thouverez M, Bertrand X, Blanc DS.

Diagn Microbiol Infect Dis. 2015 Aug;82(4):274-7. doi: 10.1016/j.diagmicrobio.2015.03.027. Epub 2015 Apr 16.

PMID:
25952482
33.

Detection of Escherichia coli sequence type 131 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: implications for infection control policies?

Lafolie J, Sauget M, Cabrolier N, Hocquet D, Bertrand X.

J Hosp Infect. 2015 Jul;90(3):208-12. doi: 10.1016/j.jhin.2014.12.022. Epub 2015 Feb 28.

PMID:
25799482
34.

Matrix-assisted laser desorption ionization-time of flight mass spectrometry identifies Pseudomonas aeruginosa high-risk clones.

Cabrolier N, Sauget M, Bertrand X, Hocquet D.

J Clin Microbiol. 2015 Apr;53(4):1395-8. doi: 10.1128/JCM.00210-15. Epub 2015 Feb 4.

35.

Population structure and antimicrobial susceptibility of Pseudomonas aeruginosa from animal infections in France.

Haenni M, Hocquet D, Ponsin C, Cholley P, Guyeux C, Madec JY, Bertrand X.

BMC Vet Res. 2015 Jan 21;11:9. doi: 10.1186/s12917-015-0324-x.

36.

Prevalence of Escherichia coli sequence type 131 and its H30 subclone among E. coli isolates in a French hospital.

Lafolie J, Nicolas-Chanoine MH, Grenouillet F, Hocquet D, Bertrand X.

Int J Antimicrob Agents. 2014 Nov;44(5):466-8. doi: 10.1016/j.ijantimicag.2014.07.016. Epub 2014 Sep 3.

PMID:
25241262
37.

Population structure of clinical Pseudomonas aeruginosa from West and Central African countries.

Cholley P, Ka R, Guyeux C, Thouverez M, Guessennd N, Ghebremedhin B, Frank T, Bertrand X, Hocquet D.

PLoS One. 2014 Sep 4;9(9):e107008. doi: 10.1371/journal.pone.0107008. eCollection 2014.

38.

Matrix-assisted laser desorption ionization-time of flight mass spectrometry assigns Escherichia coli to the phylogroups A, B1, B2 and D.

Sauget M, Nicolas-Chanoine MH, Cabrolier N, Bertrand X, Hocquet D.

Int J Med Microbiol. 2014 Nov;304(8):977-83. doi: 10.1016/j.ijmm.2014.06.004. Epub 2014 Jul 7.

PMID:
25127424
39.

Rapid, sensitive and specific detection of OXA-48-like-producing Enterobacteriaceae by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Sauget M, Cabrolier N, Manzoni M, Bertrand X, Hocquet D.

J Microbiol Methods. 2014 Oct;105:88-91. doi: 10.1016/j.mimet.2014.07.004. Epub 2014 Jul 9.

PMID:
25016131
40.

Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.

Liapis E, Pantel A, Robert J, Nicolas-Chanoine MH, Cavalié L, van der Mee-Marquet N, de Champs C, Aissa N, Eloy C, Blanc V, Guyeux C, Hocquet D, Lavigne JP, Bertrand X; ONERBA.

Clin Microbiol Infect. 2014 Dec;20(12):O1121-3. doi: 10.1111/1469-0691.12727. Epub 2014 Jul 29.

41.

Genomic analysis of the emergence of 20th century epidemic dysentery.

Rohmer L, Jacobs MA, Brittnacher MJ, Fong C, Hayden HS, Hocquet D, Weiss EJ, Radey M, Germani Y, Talukder KA, Hager AJ, Kemner JM, Sims-Day EH, Matamouros S, Hager KR, Miller SI.

BMC Genomics. 2014 May 10;15:355. doi: 10.1186/1471-2164-15-355.

42.

Comparative Genomic Analysis of Two Multidrug-Resistant Clinical Isolates of ST395 Epidemic Strain of Pseudomonas aeruginosa Obtained 12 Years Apart.

Valot B, Rohmer L, Jacobs MA, Miller SI, Bertrand X, Hocquet D.

Genome Announc. 2014 May 29;2(3). pii: e00515-14. doi: 10.1128/genomeA.00515-14.

43.

Pseudomonas aeruginosa in French hospitals between 2001 and 2011: back to susceptibility.

Slekovec C, Robert J, Trystram D, Delarbre JM, Merens A, van der Mee-Marquet N, de Gialluly C, Costa Y, Caillon J, Hocquet D, Bertrand X; ONERBA.

Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1713-7. doi: 10.1007/s10096-014-2125-8. Epub 2014 May 7.

PMID:
24800929
44.

Wastewater treatment plants release large amounts of extended-spectrum β-lactamase-producing Escherichia coli into the environment.

Bréchet C, Plantin J, Sauget M, Thouverez M, Talon D, Cholley P, Guyeux C, Hocquet D, Bertrand X.

Clin Infect Dis. 2014 Jun;58(12):1658-65. doi: 10.1093/cid/ciu190. Epub 2014 May 1.

PMID:
24795329
45.

Validation of an automated blood culture system for sterility testing of cell therapy products.

Hocquet D, Sauget M, Roussel S, Malugani C, Pouthier F, Morel P, Gbaguidi-Haore H, Bertrand X, Grenouillet F.

Cytotherapy. 2014 May;16(5):692-8. doi: 10.1016/j.jcyt.2013.09.005. Epub 2013 Nov 7.

PMID:
24210785
46.

Metronidazole increases the emergence of ciprofloxacin- and amikacin-resistant Pseudomonas aeruginosa by inducing the SOS response.

Hocquet D, Bertrand X.

J Antimicrob Chemother. 2014 Mar;69(3):852-4. doi: 10.1093/jac/dkt435. Epub 2013 Oct 24. No abstract available.

PMID:
24159155
47.

When the precautionary principle disrupts 3 years of antibiotic stewardship: nitrofurantoin in the treatment of urinary tract infections.

Slekovec C, Leroy J, Huttner A, Ruyer O, Talon D, Hocquet D, Bertrand X.

J Antimicrob Chemother. 2014 Jan;69(1):282-4. doi: 10.1093/jac/dkt328. Epub 2013 Aug 19. No abstract available.

PMID:
23960043
48.

Hospital cross-transmission of extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae.

Cholley P, Thouverez M, Gbaguidi-Haore H, Sauget M, Slekovec C, Bertrand X, Talon D, Hocquet D.

Med Mal Infect. 2013 Aug;43(8):331-6. doi: 10.1016/j.medmal.2013.06.001. Epub 2013 Jul 19.

PMID:
23876202
49.

Hospital environmental contamination with Enterobacteriaceae producing extended-spectrum β-lactamase.

Gbaguidi-Haore H, Talon D, Hocquet D, Bertrand X.

Am J Infect Control. 2013 Jul;41(7):664-5. doi: 10.1016/j.ajic.2012.07.021. Epub 2013 Jan 20. No abstract available.

PMID:
23337304
50.

Tracking down antibiotic-resistant Pseudomonas aeruginosa isolates in a wastewater network.

Slekovec C, Plantin J, Cholley P, Thouverez M, Talon D, Bertrand X, Hocquet D.

PLoS One. 2012;7(12):e49300. doi: 10.1371/journal.pone.0049300. Epub 2012 Dec 19.

Supplemental Content

Loading ...
Support Center